testolactone (Teslac, Fludestrin)

Indications: - adjunctive therapy in palliative treatment of metastatic breast cancer (post-menopausal or with ovariectomy) Laboratory: - testolactone in urine Mechanism of action: - inhibition of steroid aromatase activity

General

aromatase inhibitor antineoplastic agent (chemotherapeutic agent)

References

- RxList http://www.rxlist.com/teslac-drug.htm